Skip to content

Insider · CIK 0002030378

Suzanne Campion

director

Files at ARDT (Ardent Health, Inc.). First filing -, latest -.

Suzanne Campion files SEC Form 4 as director at ARDT (Ardent Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Suzanne Campion has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 1, 2026ARDT
Ardent Health, Inc.
AGrant or award
Common Stock
+14,231$0.00$058,215Apr 2, 2026
Mar 21, 2025ARDT
Ardent Health, Inc.
AGrant or award
Common Stock
+12,916$0.00$043,984Mar 25, 2025
Dec 12, 2024ARDT
Ardent Health, Inc.
AGrant or award
Common Stock
+10,793$0.00$031,068Dec 16, 2024

Questions about Suzanne Campion

Answered from the filings on this page, as of the latest one.

Is Suzanne Campion buying or selling?

Suzanne Campion has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Suzanne Campion's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Suzanne Campion has 0.

Where does Suzanne Campion file Form 4?

Suzanne Campion has filed Form 4 at ARDT (Ardent Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Suzanne Campion: insider trades and track record | InsiderTell